Corporate Banner
Satellite Banner
Metabolomics & Lipidomics
Scientific Community
Become a Member | Sign in
Home>News>This Article

UC Davis Receives $9.3 Million Grant for Metabolomics Center

Published: Monday, September 10, 2012
Last Updated: Monday, September 10, 2012
Bookmark and Share
The new center will bring together existing UC Davis service facilities in mass spectrometry, nuclear magnetic resonance and imaging.

With a $9.3 million startup grant from the National Institutes of Health, the University of California, Davis, has announced plans to open the West Coast Metabolomics Center, a high-tech consortium of research and service laboratories that will help scientists better understand and develop more effective treatments for complex diseases like diabetes, cancer and atherosclerosis.

The facility, which will be housed within the UC Davis Genome Center, will celebrate its grand opening Oct. 8 with a mini-symposium featuring UC Davis and regional scientists, and corporate supporters.

Metabolomics is a new field that looks at the biochemical changes taking place in living cells during metabolism. The West Coast Metabolomics Center at UC Davis will use more than 30 mass spectrometers — instruments for analyzing chemical structures — to target thousands of different molecules produced in cells, allowing researchers to look at changes taking place at specific times and under specific environmental conditions.

“The NIH recognizes metabolism as a very important part of human physiology and disease processes,” said Oliver Fiehn, professor of molecular and cellular biology and director of the new center. “When you analyze metabolism, you can tell the state of the body at the onset and during the progression of diseases ranging from cardiovascular disease to cancer.”

It will help researchers throughout the western U.S. with small grants for annual pilot and feasibility studies, provide courses, statistics and bioinformatics services, and perform metabolomic analyses on a fee-for-service basis. The center is designed to be self-sustaining within five years.

One of researchers who plans to use the new center is UC Davis Professor Bruce German, who studies lipid metabolism, especially in milk production, in the Department of Food Science and Technology.

“This new center shows the effects of the university’s long-term investments into biochemistry and genomics,” German said.

Juvenile diabetes
One of the center's first big projects will be as part of a large international study, led by the NIH, to look for environmental causes of childhood diabetes. Juvenile, or Type 1 diabetes is an autoimmune disease that causes the body to destroy pancreatic cells that produce insulin, and people with the disease must inject insulin regularly in order to survive.

Called the TEDDY study — The Environmental Determinants of Type 1 Diabetes in the Young — the project will track nearly 8,000 children over a three-year period to try to identify factors such as infections, diet, stress or other conditions that may trigger the disease.

“We know that children who get Type 1 diabetes all have certain gene signatures, but most children with those same genes don’t get the disease,” Fiehn said. “Researchers now believe there’s an environmental trigger — something that activates those genes and causes the disease. Metabolomics is a way to try to identify those environmental triggers by seeing what’s happening inside the cells over time. In addition, metabolomics is a chemical screening tool that might find further environmental cues, including pollutants.”

The West Coast Metabolomics Center will analyze blood samples taken from children every three months during the study period, providing data to researchers that may help them identify a single factor or series of factors that trigger the disease. The TEDDY consortium will pay more than $1.5 million for the services provided by the new center.

Individualized medicine
Another promising aspect of metabolomics research is creating individualized treatments for people with certain diseases, or choosing the best available treatment for a patient.

Metabolomics could be used to determine the best dose of treatment for a patient. People with higher metabolisms may need higher doses of drugs than people with lower metabolisms, for example.

"Understanding metabolomics and disease response will help scientists to develop new therapeutic strategies," said Professor Ralph de Vere White, director of the UC Davis Comprehensive Cancer Center. "This metabolomics research center will allow the UC Davis Comprehensive Cancer Center to advance this exciting area in cancer research, more deeply understand underlying mechanisms, and improve treatment options for patients."

The West Coast Metabolomics Center at UC Davis has received instrumentation support from mass spectrometry equipment companies Agilent Inc. and LECO Corporation.

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,800+ scientific posters on ePosters
  • More than 4,000+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Scientific News
Gut Microbes Signal to the Brain When They're Full
Don't have room for dessert? The bacteria in your gut may be telling you something.
Turning up the Tap on Microbes Leads to Better Protein Patenting
Mining millions of proteins could become faster and easier with a new technique that may also transform the enzyme-catalyst industry, according to University of California, Davis, researchers.
Drug May Prevent Life-Threatening Muscle Loss in Advanced Cancers
New data describes how an experimental drug can stop life-threatening muscle wasting (cachexia) associated with advanced cancers and restore muscle health.
Cancer-Fighting Tomato Component Traced
The metabolic pathway associated with lycopene, the bioactive red pigment found in tomatoes, has been traced by researchers at the University of Illinois.
Circadian Clock Controls Insulin and Blood Sugar in Pancreas
Map of thousands of genes suggests new therapeutic targets for diabetes.
Cellular Stress Process Identified in Cardiovascular Disease
Combining the investigative tools of genetics, transcriptomics, epigenetics and metabolomics, a Duke Medicine research team has identified a new molecular pathway involved in heart attacks and death from heart disease.
Predicting Adverse Drug Reactions with Higher Confidence
A new integrated computational method helps predicting adverse drug reaction—which are often lethal—more reliably than with traditional computing methods.
A New Way to Starve Lung Cancer?
Metabolic alterations in lung cancer may open new avenues for treating the disease.
Evidence of How Incurable Cancer Develops
Researchers in the West Midlands have made a breakthrough in explaining how an incurable type of blood cancer develops from an often symptomless prior blood disorder.
Building a Better Liposome
Computational models suggest new design for nanoparticles used in targeted drug delivery.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos